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Unrestricted pore area (A0 /Dx) is a better indicator of perito- treated with peritoneal dialysis (PD) [3], but there is a
neal membrane function than PET. great variation in the PD frequency among different
Background. How to measure the peritoneal exchange in countries. In most studies, the long-term patient mortalityuremic patients treated with peritoneal dialysis (PD) is still a
and morbidity of PD have been shown to be similar tomatter of controversy. Most clinics use the peritoneal equilibra-
that of hemodialysis (HD) [4, 5], even though PD is stilltion test (PET), but from a theoretical point of view, it would
be more appropriate to determine the “area” parameter, associated with a higher rate of technique failures than
A0/Dx. The latter reflects the total unrestricted pore area per HD [4, 6]. Therefore, considerable interest has been fo-
centimeter diffusion distance and can be obtained by three- cused on infectious complications [3], long-term durabilitypore analysis using, for example, the PD capacity test (PDC).
of the peritoneal membrane [7, 8], dialysis adequacyTo evaluate the different estimates of peritoneal function, PET
[3, 9], and metabolic side effects, such as hyperglycemia,data and the A0/Dx parameters were compared with the inde-
pendently determined uptake of a small diffusible tracer, io- hyperlipidemia, and hypoalbuminemia [10]. Indeed, a
hexol (molecular weight of 821 D), from the abdominal cavity markedly reduced incidence of peritonitis together with
to blood. improvements of the technical devices and PD solutionsMethods. Fourteen patients on routine PD underwent deter-
has contributed to enhancement of its long-term tech-minations of PET and A0/Dx using PDC. Within a month, the
nique survival [11–16].two-hour uptake of iohexol (6 mg/mL) was also determined
from the plasma iohexol concentration following abdominal The effort to measure and individualize the dialysis
filling. dose is another important factor that contributes to the
Results. A strong correlation was found between the rate improved clinical outcome of PD. Hence, it was recog-of iohexol plasma concentration increase (k30–120) and A0/Dx
nized early that there are large differences between indi-(A0/Dx 5 76,300 · k30–120 2 1.56; r 2 5 0.799; N 5 14) for the 2 L
dwell, while the PET data were far less related to iohexol vidual patients treated with PD regarding the exchange
uptake (D/DPurea, r 2 5 0.409; D/Pcreatinine, r 2 5 0.436; and of solutes and fluid [17]. Moreover, there is no evident
D/D0glucose, r 2 5 0.015, respectively). relationship between the peritoneal capacity for dialysis
Conclusion. The “area” parameter, A0/Dx, is superior to the and external measurable variables, such as age, gender,more widely used routine PET as an indicator of peritoneal
body weight, and/or body surface area. Different meth-membrane function. In addition, the concept of A0/Dx has the
virtue of supplying quantitative information about the perito- ods have therefore been introduced and aimed at esti-
neal pathophysiology and physiology. mating the PD capacities of individual patients. The most
widely used technique is the peritoneal equilibration test
(PET) [18], which utilizes the dialysate over plasma
After the initial description of continuous ambulatory (D/P) concentration ratios for urea, creatinine, and the
peritoneal dialysis (CAPD) [1], this life-supporting ther- D/D0 ratio for glucose to estimate peritoneal function.
apy has become increasingly popular for patients with Using a 2 L dwell with an intermediate glucose concen-
chronic renal failure [2]. Worldwide, approximately 15% tration (22.7 mg/mL) for four hours standardizes the
of the patients needing renal replacement therapy are conditions. There is also computer software that is based
on PET data. Another approach to evaluate the func-
tional properties of peritoneum is to apply the personalKey words: iohexol, dialysis capacity, uremia, fluid exchange, pore area
test, CAPD, peritoneal exchange capacity. dialysis capacity (PDC) test, which is based on a three-
pore analysis of the peritoneal membrane [19]. Few at-Received for publication June 22, 1999
tempts have been made to evaluate the possible medicaland in revised form February 25, 2000
Accepted for publication April 28, 2000 advantages of using one technique rather than the other,
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exchange as part of their quality control of patients on indications that iohexol influences the renal function per
se [28, 29].PD. We do know that the patients that are classified as
Iohexol concentrations in plasma were analyzed by“high transporters” using PET statistically have in-
high-performance liquid chromatography (HPLC) [30].creased risks for morbidity and mortality [20]. The rea-
Also, the dialysate iohexol concentration was analyzedsons for the association are presently unknown [21],
immediately before and directly after the PD exchange.although overhydration is one plausible explanation
Calculations. A small but significant background ac-[22, 23].
tivity in plasma was subtracted from the iohexol concen-The present study was undertaken to evaluate how
trations. Moreover, the concentrations were divided bywell the two techniques, PET and PDC, estimate the
the initial concentration of iohexol in the PD fluid toperitoneal exchange capacity compared with the inde-
correct for small variations in dose. For each patient andpendently determined uptake of a small diffusible tracer,
dialysis session, the linear regression slope was calculatediohexol, from the abdominal cavity to blood.
for the relationship of the plasma iohexol concentration
versus time. The start of dialysate filling was defined as
METHODS time zero. The linear regression slope in the time interval
Study group 30 to 120 minutes (k30–120) was subsequently related to
the A0/Dx from the PDC test of each patient.Fourteen patients, 1 woman and 13 men (age 63 6
3.7 years, body weight 78 6 2.8 kg), with end-stage renal
Functional characteristics of the peritoneal membranedisease and who were on maintenance PD (treatment
For each patient, the PDC test was determined withinduration 19 6 3 months) participated in the investigation,
a four-week period to the experimental dialysis sessions.which was approved by the ethical committee of Go¨te-
The computerized PDC program allowed for an assess-borg University (Go¨teborg, Sweden). All patients were
ment of the functional peritoneal capacity for dialyticrecruited from the Sahlgrenska University Hospital, and
exchange based on the three-pore concept for transcapil-they gave their written informed consent before entering
lary exchange [19]. PDC is described by three physiologi-the study. The underlying disease of the uremic condition
cal parameters: (1) The “area parameter” or the un-showed the panorama that is common in a dialysis popu-
restricted pore area per centimeter (cm) of diffusionlation, and each patient was regarded to be in a stable
distance (A0/Dx), which determines the diffusion of smallclinical condition during the time period of the study.
solutes and the hydraulic conductance of the membraneThe patients were selected to represent a wide range of
(LpS); (2) the JvAR, which is the final reabsorption rateperitoneal function (discussed in the Results section).
of fluid from the abdominal cavity to blood when the
glucose gradient has dissipated; and (3) the plasma lossStudy protocol
(JvL) that determines the loss of proteins from blood toIohexol uptake technique. The study protocol in-
the abdominal cavity through the large pores.cluded two dwells in a crossover fashion on separate
The PET was based on a four-hour exchange with 2 Ldays, with dialysate volumes of 0.5 and 2 L, respectively.
of 2.27% (or 2.5%) glucose solution. The D/P ratios forEach study session started with filling of fresh dialysate
urea and creatinine were calculated together with thefluid (1.5 to 2.5% glucose) containing the tracer iohexol.
dialysate glucose concentration at four hours over theVenous blood samples for analyses of iohexol were re-
initial concentration (D/D0). The creatinine concentra-peatedly taken immediately before the start of filling
tions were corrected for the interference with glucoseand during the subsequent two-hour dwell period at 30,
using the following Jaffe correction:60, 90, and 120 minutes (N 5 5). Thereafter, the abdomen
was drained, and the patient was returned to his or her D-[creat]true 5 D-[creat]measured 2 0.285 · D-[glucose]
ordinary PD protocol.
where the correction factor of 0.285 was independently
Tracer. Standard dialysates were used, and iohexol
determined by us and valid for our laboratory.
(300 mg/mL; Omnipaquet, Nycomed, Sweden) was add-
ed to reach a concentration of 6 mg/mL (40 mL Omnipa- Statistical methods
quet to 2 L and 10 mL to the 0.5 L dialysate volume, Results are presented as means 6 SE. Linear regres-
respectively). sion analysis (r 5 Pearson’s correlation coefficient,
Iohexol is a nonionic x-ray medium with a molecular d.o.f. 5 degrees of freedom) was performed where ap-
weight of 821 D. Normally, it is eliminated from plasma propriate.
in intact form by glomerular filtration (extrarenal clear-
ance of approximately 2 mL/min) [24], but it is also
RESULTSremoved by dialysis [25–27]. Iohexol clearance has, in
some clinics, become the routine method for determina- Fourteen patients participated in two experimental
PD sessions with dialysate dwell volumes of 2 and 0.5 Ltion of the glomerular filtration rate, and there are no
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Fig. 1. Plasma concentrations of iohexol after
abdominal filling with 2 L of peritoneal dial-
ysis (PD) fluid containing iohexol (6 mg/mL,
N 5 14).
and dialysate iohexol concentrations of 6.02 6 0.04 and a 2 L PD dwell gave the following relationship: A0/Dx 5
76,300 · k30–120 2 1.56, r 2 5 0.799, and hence a Pearson’s5.99 6 0.00 mg/mL, respectively (P 5 NS). No adverse
events occurred during or between the PD sessions. The correlation coefficient of 0.894 (N 5 14; Fig. 2). This
0.5 L PD dwell gave fill volumes of 258 6 6 mL/m2 or equation was used to convert the rate constant for io-
6.6 6 0.3 mL/kg, whereas the 2 L dwell gave fill volumes hexol uptake to A0/Dx for 2 L and 0.5 L PD dwells. Such
of 1030 6 23 mL/m2 or 26.2 6 1.1 mL/kg. analysis revealed that the effective A0/Dx is considerably
smaller with the low fill volume of 0.5 L compared with
Basic PET data that of 2 L (Fig. 3).
The dialysate over plasma concentration ratio for urea
Relationship between PET data and iohexol uptake(D/Purea) after four hours with 2 L of 2.27 or 2.5% glucose
intraperitoneally was 0.878 6 0.011 (range 0.793 to The relationship between the PET data and the rate
0.961). D/P for creatinine was 0.629 6 0.023 (range 0.516 constant for iohexol uptake is demonstrated in Figure
to 0.783), and D/D0 for glucose was 0.319 6 0.012 (range 4. The correlation between D/Purea and k30–120 gave the
0.229 to 0.387). following regression equation: D/Purea 5 0.458 · k30–120 1
0.755 (r 2 5 0.409). The corresponding regression equa-
The unrestricted pore area, A0 /Dx, from PDC tions for D/Pcreatinine and D/D0glucose were 0.957 · k30–120 1
The average unrestricted pore area over diffusion dis- 0.373, r 2 5 0.436, and D/D0glucose 5 20.094 · k30–120 1 0.344
tance, A0/Dx, as determined by the PDC test, was (r 2 5 0.015), respectively (Fig. 4).
18,800 6 1270 cm2/cm/1.73 m2 BSA, with a range of
11,400 to 26,500. The corresponding A0/Dx for the 0.5 L
DISCUSSIONvolume was 4800 6 490 cm2/cm/1.73 m2 BSA (range 1800
The hypothesis of a relationship between the perito-to 7500). The distribution was not random since patients
neal capillary uptake of a tracer and the functional peri-were selected on the basis of previous PDC tests in order
toneal area available for dialytic exchange (A0/Dx) couldto represent a broad spectrum of peritoneal capacities.
be confirmed by the results of the present study. Thus,
Rate constant for iohexol uptake for the larger dwell volume (2 L), there was a strong
correlation between the rate of plasma iohexol concen-Figure 1 shows the plasma concentration of iohexol
tration increase and the functional peritoneal area as-against time after the start of the abdominal fill. The
sessed by PDC measurements, while the PET data wererate constant for iohexol uptake (k30–120) was 0.267 6
far less related to the iohexol uptake.0.015 min21 (range 0.170 to 0.368) for 2 L of intraperito-
The study included patients with PD as their mainte-neal fill volume and 0.084 6 0.006 min21 (range 0.043 to
nance renal replacement therapy, and they have rou-0.119) for 0.5 L dialysate volumes.
tinely performed PDC measurements. They were se-
Relationship between A0 /Dx and iohexol uptake lected to represent a spectrum of different functional
peritoneal capacities (Fig. 1). The standard curve calcu-Linear regression analysis of A0/Dx determined by the
PDC test and the rate constant for iohexol uptake after lated for the area parameter versus plasma iohexol con-
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Fig. 2. Unrestricted pore area per cm diffu-
sion distance (A0 /Dx) as determined by a
three-pore analysis of a peritoneal dialysis ca-
pacity (PDC) test plotted against the relative
rate of plasma concentration increase, k30–120,
after intraperitoneal administration of iohexol
in 2 L of PD fluid. The linear regression analy-
sis gave the following relationship: A0/Dx 5
76300 · k30–120 2 1.56 (r2 5 0.799, N 5 14).
Fig. 3. The rate of the increase in plasma con-
centration (k30–120) after an intraperitoneal ad-
ministration of iohexol can be converted to
A0 /Dx using the relationship in Figure 2. This
graph illustrates such A0/Dx values calculated
from the rate constant for iohexol uptake
against the individual fill volume (mL/kg, N 5
14) for the 0.5 and 2 L PD dwells, respectively.
The A0/Dx is significantly increased after ap-
plication of the larger fill volume. Also shown
is the line of identity.
centration should thereby be representative for varying solutes and fluid is only partially utilized, to varying
degrees in different patients. The k30–120 value of 0.10 forcharacteristics of the peritoneal membrane. The strong
correlation between k30–120 and A0/Dx for the 2 L PD the 0.5 L intraperitoneal volume would suggest that on
average only 35 to 40% of the “area” is utilized comparedsolution validates the three-pore concept as used in the
PDC program [19]. Thus, if the total pore area available with the 2 L solution. This probably explains why a
small intraperitoneal volume is not reabsorbed as fastfor exchange (per cm of diffusion distance, A0/Dx) is
known, it is possible to estimate the transperitoneal pas- as expected based on the “area” parameter determined
using “normal” abdominal fill volumes.sage for any solute. In the present study, the uptake of
iohexol was found to be in direct proportion to the A0/Dx, The intermediate-sized molecule iohexol seems to be
a useful marker of the peritoneal exchange when a suffi-at least for the 2 L exchange. For 0.5 L of PD fluid, the
relationship was less reliable. Hence, it seems important cient dwell volume is used. This is in analogy with results
from a recent study in patients with end-stage renal dis-to use adequate dwell volumes for studies of iohexol
uptake after an intraperitoneal injection. ease and HD treatment where iohexol was found to
be a representative tracer for the capillary exchange ofThe lower dwell volume of 0.5 L is probably not suffi-
cient to be evenly distributed in the abdominal cavity. solutes in the dialytic situation [31].
For patients with end-stage renal failure, it would beThereby, the peritoneal area available for exchange of
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Fig. 4. (A) Dialysate over plasma (D/P) con-
centration ratios for urea after four-hour
dwells with 2 L of 2.27% glucose solutions
plotted against the rate constant for iohexol
uptake (k30–120). D/Purea 5 0.458 · k30–120 1 0.755
(r2 5 0.409, N 5 14). (B) D/Pcreatinine plotted
against the rate constant for iohexol uptake
(k30–120). Linear regression analysis gave the
following relationship: D/Pcreatinine 5 0.957 3
k30–120 1 0.373 (r2 5 0.436, N 5 14). (C)
D/D0glucose versus the rate constant for iohexol
uptake (k30–120) yielded the following regres-
sion analysis: D/D0glucose 5 20.094 · k30–120 1
0.344 (r2 5 0.015, N 5 14).
Johnsson et al: Peritoneal exchange area and uptake of iohexol1778
Reprint requests to Bo¨rje Haraldsson, M.D., Ph.D., Department ofuseful to assess the peritoneal functional characteristics
Physiology, P.O. Box 432, SE-405 30 Go¨teborg, Sweden.
before maintenance PD is started. However, the present E-mail: bharalds@fysiologi.gu.se
study shows that 2 L dwell volumes containing iohexol
need to be used in order to predict peritoneal function
APPENDIXadequately, that is, A0/Dx. Therefore, the iohexol uptake
Estimated transperitoneal passage of iohexolapproach is suitable for patients on PD, but may cause
The final reabsorption rate of fluid from the abdominal cavity topractical problems for those who do not yet have a PD
blood, JvAR, is on average 1.2 mL/min. This includes lymph flow andcatheter. reabsorption across the capillary walls [19]. Assuming that at least
70% of the JvAR will contain iohexol, a mass transfer area coefficientThe standardized PET is still the most widespread
(MTAC) for iohexol across the peritoneal membrane of 5 mL/min willtool for assessment of peritoneal exchange capacity, and
give a total peritoneal to blood clearance (KPD5.B) of 5.85 mL/min.variations in PET are often interpreted in terms of The MTAC is given by the following expression:
“transport” or peritoneal permeability. The changes in
MTAC 5 (A0/Dx) · (Ap/A0) · D378C (Eq. 1)dialysate over plasma concentration ratios (D/P, dis-
where A0/Dx is the unrestricted pore area over diffusion distance, Ap/A0cussed previously in this article) are noteworthy, and
is the pore restriction factor for a given solute, and D is the free
hence, PET does not provide clear information of under- diffusion coefficient [19]. Thus, MTAC for a certain solute is directly
proportional to the area parameter, A0/Dx.lying mechanisms in the peritoneal membrane. Factors
such as the area available for exchange (A0/Dx), the
Measured iohexol concentration before and after a two-hourintraperitoneal volume, the rate of “ultrafiltration,” the
PD dwell
lymph flow, as well as the pore size and relative pore
The iohexol concentrations in the PD fluid were determined before
distribution may all affect the D/P concentration ratios, the start of the dwell and after two hours of dialysis, based on the
mean of duplicate samples. The initial concentration was close to 6and therefore the PET results. In accordance with this
mg/mL. The concentration of iohexol in the drain solution was cor-observation, the PET data of our present study were
rected for the diluting effects of the estimated residual volume and of
substantially more scattered and less correlated to the the ultrafiltration. The iohexol concentration in the drain fluid was
70.4% (SEM 5.2%, N 5 13) of the initial concentration for a fill volumeplasma uptake of iohexol than the corresponding PDC
of 2 L, and 57.1% (SEM 5.0%, N 5 12) for a fill volume of 0.5 L.results.
The three-pore concept for transcapillary exchange Calculated iohexol concentration in the dialysate
[32], which has been applied to PD [33, 34], offers a basic Initially, the blood concentration of iohexol is zero, and the intra-
peritoneal concentration [Cip(0)] is 6 mg/mL. An estimate of the intra-physiological description of solute and fluid transport in
peritoneal concentration at time t, Cip(t), can be obtained using thePD. The PDC test is based on the three-pore model and following compartmental analysis:
allows for determinations of the transport characteristics
Cip(t)/Cip(0) 5 e2K·t/Vip (Eq. 2)of the peritoneal membrane in individual patients [19].
Hence, the PDC has become a useful tool to secure The expression to the left is the concentration of iohexol in the dialysate
at time (t; in minutes) as a fraction of the initial Cip. Thus, for anadequate dialysis and to improve the understanding of
intraperitoneal volume (Vip) of 2000 mL, a time (t) of 120 minutes andPD exchange. Furthermore, the PDC parameters have a clearance (K) of 4.85 mL min21, the calculated Cip(120) would be
70.4%, that is, equivalent to the experimentally determined value.been shown to be reliable as well as highly reproducible
Repeating the calculations for a fill volume (Vip) of 500 mL wouldand to allow for adequate predictions of the dialysis
give a calculated Cip(120) of 24.6%, which is less than half of thatefficacy in both adults [19] and children [35]. experimentally determined. This means that clearance in the situation
with a fill volume of 500 mL must be reduced compared with the KTo summarize, we have compared the plasma appear-
for a Vip of 2000 mL.ance rate after intraperitoneal administration of iohexol
(k30–120) with two other methods of estimating peritoneal Estimating MTAC and A0/Dx with a low fill volume
function: PET and the area parameter of PDC. The The total clearance is composed of MTAC 1 0.85 mL min21 (dis-
cussed previously in the Appendix), and MTAC is proportional to A0/Dx.plasma appearance rate of intraperitoneal iohexol is highly
Dividing A0/Dx (and hence MTAC) by 3.37 would therefore result incorrelated to the area parameter (A0/Dx) of the PDC test, a K of 2.33 mL min21. Inserting this K, a Vip of 500 mL and a t of 120
while PET correlates substantially less to the peritoneal minutes into equation 2 results in a Cip(t) of 57.0% of the initial
intraperitoneal concentration, which is similar to the experimentallypore area or the k30–120. We conclude that the bluntness
determined value. If A0/Dx is 18,000 cm2 · cm21 with a 2 L dwell, thenof PET as a tool for estimating peritoneal function stands it would be expected to be 5300 cm2 · cm21 for an intraperitoneal fill
in sharp contrast to its widely spread clinical use. volume of 0.5 L. This value is not far from that determined from
independent estimates of the uptake of iohexol from the abdominal
cavity to blood (discussed in the Results section).ACKNOWLEDGMENTS
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